Charles Schwab’s PhenomeX Inc. Common Stock CELL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-27,503
| Closed | -$27.5K | – | 3613 |
|
|
2023
Q3 | $27.5K | Sell |
27,503
-284,468
| -91% | -$218K | ﹤0.01% | 3480 |
|
|
2023
Q2 | $153K | Sell |
311,971
-174,719
| -36% | -$143K | ﹤0.01% | 3327 |
|
|
2023
Q1 | $565K | Buy |
486,690
+72,911
| +18% | +$133K | ﹤0.01% | 2911 |
|
|
2022
Q4 | $1.11M | Buy |
413,779
+36,319
| +10% | +$95.7K | ﹤0.01% | 2744 |
|
|
2022
Q3 | $1.08M | Buy |
377,460
+50,540
| +15% | +$215K | ﹤0.01% | 2769 |
|
|
2022
Q2 | $1.63M | Buy |
326,920
+29,950
| +10% | +$157K | ﹤0.01% | 2626 |
|
|
2022
Q1 | $2.11M | Sell |
296,970
-11,549
| -4% | -$95.5K | ﹤0.01% | 2631 |
|
|
2021
Q4 | $5.61M | Buy |
308,519
+4,545
| +1% | +$98.1K | ﹤0.01% | 2292 |
|
|
2021
Q3 | $5.95M | Buy |
303,974
+157,844
| +108% | +$6M | ﹤0.01% | 2293 |
|
|
2021
Q2 | $6.55M | Buy |
146,130
+102,807
| +237% | +$4.77M | ﹤0.01% | 2220 |
|
|
2021
Q1 | $2.18M | Buy |
43,323
+4,857
| +13% | +$331K | ﹤0.01% | 2641 |
|
|
2020
Q4 | $3.44M | Buy |
38,466
+2,765
| +8% | +$233K | ﹤0.01% | 2399 |
|
|
2020
Q3 | $2.73M | Buy |
+35,701
| New | +$2.27M | ﹤0.01% | 2381 |
|
Charles Schwab's CELL Position: Q4 2023 in Review
Charles Schwab sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2023, closing a stake of 27,503 shares — an estimated $27.5K sold.
Charles Schwab first reported a position in CELL in Q3 2020 and held it in 13 quarters. The position peaked at $6.55M in Q2 2021. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.
- Charles Schwab reported no remaining PhenomeX Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Charles Schwab sold 27,503 PhenomeX Inc. Common Stock shares in Q4 2023, an estimated $27.5K.
- Charles Schwab first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 13 quarters.
- Charles Schwab's PhenomeX Inc. Common Stock position peaked at $6.55M in Q2 2021.
- 0 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2023.
Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.